期刊文献+

儿茶酚胺介导的多形性室速患者家系CASQ2基因F189L突变的基因分析 被引量:4

A Novel mutation of F189L in CASQ2 in families with catecholaminergic polymorphic ventrictdar tachycardia
原文传递
导出
摘要 目的在27例儿茶酚胺介导的多形性室速患者及家庭成员中寻找CASQ2基因突变。方法应用直接DNA序列分析对临床诊断为家族性多形性室速27例患者及家庭成员进行进行基因突变分析。应用Taqman基因分型检测在以1400名正常人群中确定CASQ2变异的频率。结果在一个多形性室速家系中发现了1个新的杂合子改变F189L。通过与多种生物比对,证实该改变发生于在第2结构域一个高度保守的氨基酸上,位于第5外显子的F189L的改变,使编码蛋白的第189位氨基酸由苯丙氨酸改变为亮氨酸。应用Taqman SNP genotyping assay分析方法证实正常人群1400名中未发现同样改变。在CASQ2基因中未发现其他引起疾病的基因突变。结论发现了CASQ2基因的1个新F189L突变。 Objective To identify mutations and variants in CASQ2 gene in 27 CPVT patients/family members. Methods Mutational analysis was performed with direct DNA sequence analysis. The frequency of an identified CASQ2 variant was determined using the Taqman genotyping assay. Results A novel heterozygons mutation, F189L, in CASQ2 gene was identified in one family with CPVT. This mutation occurred at the evolutionarily, highly conserved phenylalanine residue at codon 189, and was not present in 1400 control individuals. No other disease-cansing mutations were identified in the CASQ2 gene. Conclusion A novel of F189L in the CASQ2 gene was identified.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2008年第3期334-337,共4页 Chinese Journal of Medical Genetics
基金 美国NIH R01 HL66251(Q.K.W)基金 国家重点基础研究发展计划资助“973”项目(2007CB512001和2007CB512002) 国家留学基金委中美联合培养博士项目(2006:3037) 美国心脏学会杰出研究员奖(0440157N)
关键词 心律失常 儿茶酚胺介导的多形性室速 CASQ2基因 arrhythmias eatecholaminergie polymorphie ventrieular taehyeardia CASQ2 gene
作者简介 通信作者:胡大一,E-mail:dayihu@medmail.com.cn 通信作者:王擎,E-mail:wangq2@ccf.org
  • 相关文献

参考文献12

  • 1Otsu K, Fuji J, Periasamy M, et al. Chromosome mapping of five human cardiac and skeletal muscle sarcoplasmie retieulum protein genes. Genomics, 1993,17 : 507-509.
  • 2Bhuiyan ZA, Hamdan MA, Shamsi ET, et al. A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiov Electroph , 2007,18 : 1060-1066.
  • 3Lahat H, Pras E, Olender T, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet,2001,69:1378-1384.
  • 4Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive cate- cholamine-or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation ,2001,103 : 2822-2827.
  • 5Dirksen WP, Lacombe VA, Chi M, et al. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca^2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res ,2007,75:69-78.
  • 6Postma AV, Denjoy I, Hoomtje TM, et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res, 2002, 91:21-26.
  • 7Terentyev D, Nori A, Santoro M, et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res, 2006,98 : 1151-1158.
  • 8di Barletta MR, Viatchenko-Karpinski S, Nori A, et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with eatecholaminergle polymorphic vantrieular tachycardia. Circulation, 2006, 114: 1012-1019.
  • 9Knollmann BC, Chopra N, Hlaing T, et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca^2+ release, and catecholaminergic polymorphic ventricular lachycardia. J Clin Invest, 2006,116 :2510-2520.
  • 10Song L, Alcalai R, Arad M, et al. Calsequestrin 2 ( CASQ2 ) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest, 2007, 117 : 1814-1823.

同被引文献60

  • 1郭成军,张英川,方冬平,刘冰,郝鹏,李庆祥,何东方,李果.导管消融治疗短QT综合征患者多频率室性心动过速和心室颤动一例[J].中华心血管病杂志,2005,33(1):90-91. 被引量:12
  • 2杨兵,曹克将,单其俊,李库林,夏耘,涂静,袁斌斌,龚杰.1 065例健康汉族人Brugada心电图征发生率的初步调查[J].中华心律失常学杂志,2005,9(3):214-217. 被引量:24
  • 3王祖禄,黄从新,梁延春,韩雅玲,梁明,马薇.应用电解剖标测系统引导经盐水灌注导管消融法洛四联症术后的室性心动过速[J].中华心律失常学杂志,2007,11(2):95-102. 被引量:9
  • 4Nakajima T,Kaneko Y,Taniguchi Y,et al.The mechanism of catecholaminergic polymorphic ventricular tachycardia may be triggered activity due to delayed afterdepolarization.Eur Heart J,1997,18:530-531.
  • 5Viatchenko-Karpinski S,Terentyev D,Gy6rke I,et al.Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.Circ Res,2004,94:471-477.
  • 6Faber CM,Rudy Y.Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia:a simulation study of cellular mechanism.Cardiovasc Res,2007,75:79-88.
  • 7Liu N,Colombi B,Memmi M,et al.Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia; insights from a RyR2 R4496C knock-in mouse model.Circ Res,2006,99; 292-298.
  • 8Song L,Alcalai R,Arad M,et al.Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors,causing catecholaminergic polymorphic ventricular tachycardia.J Clin Invest,2007,117:1814-1823.
  • 9Kannankeril PJ,Mitchell BM,Goonasekera SA,et al.Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.Proc Natl Acad Sci USA,2006,103:12179-12184.
  • 10Sumitomo N,Harada K,Nagashima M,et al.Catecholaminergic polymorphic ventricular tachycardia:electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.Heart,2003,89:66-70.

引证文献4

二级引证文献410

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部